Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Carter

Showing results (71-80 of 142) with videos related to

Pageof 15
Sort By:
Journal of Neurochemistry|January 1, 1980
Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on neurotransmitter systems in subcortical sites in the ratC J Pycock, C J Carter, R W Kerwin
Immunology|July 1, 1985
Activation and proliferation signals in mouse B cells. VI. Anti-Ig antibodies induce dose-dependent cell cycle progression in B cellsG G Klaus, C M Hawrylowicz, C J Carter
Biochemical Society Transactions|August 1, 1979
A mutant of Saccharomyces cerevisiae that possesses unusual ribosomes [proceedings]M Cannon, C J Carter, J Davies, et al.
Progress in Hemostasis and Thrombosis|January 1, 1989
Anticoagulant therapy for venous thromboembolismG E Raskob, C J Carter, R D Hull
Annals of Internal Medicine|May 1, 1990
Serial impedance plethysmography in pregnant patients with clinically suspected deep-vein thrombosis. Clinical validity of negative findingsR D Hull, G E Raskob, C J Carter
Nature|July 3, 1980
Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in ratsC J Pycock, R W Kerwin, C J Carter
Blood|March 1, 1982
Sex related differences in platelet function: the effect of aspirinJ G Kelton, C J Carter, A Santos, et al.
Thrombosis Research|May 1, 1980
A comparison of the quantitative ristocetin von Willebrand factor assay by using fresh and fixed plateletsJ G Kelton, J Bishop, C J Carter, et al.
Thrombosis Research|November 1, 1982
Discordance between the anti-Xa activity and the antithrombotic activity in an ultra-low molecular weight heparin fractionP A Ockelford, C J Carter, L Mitchell, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|June 1, 1993
Platelet-associated factor XIII as a marker of platelet activation in patients with peripheral vascular diseaseD V Devine, G Andestad, D Nugent, et al.
Pageof 15

Showing results (71-80 of 142) with videos related to

Sort By:
Pageof 15
Journal of Neurochemistry|January 1, 1980
Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on neurotransmitter systems in subcortical sites in the ratC J Pycock, C J Carter, R W Kerwin
Immunology|July 1, 1985
Activation and proliferation signals in mouse B cells. VI. Anti-Ig antibodies induce dose-dependent cell cycle progression in B cellsG G Klaus, C M Hawrylowicz, C J Carter
Biochemical Society Transactions|August 1, 1979
A mutant of Saccharomyces cerevisiae that possesses unusual ribosomes [proceedings]M Cannon, C J Carter, J Davies, et al.
Progress in Hemostasis and Thrombosis|January 1, 1989
Anticoagulant therapy for venous thromboembolismG E Raskob, C J Carter, R D Hull
Annals of Internal Medicine|May 1, 1990
Serial impedance plethysmography in pregnant patients with clinically suspected deep-vein thrombosis. Clinical validity of negative findingsR D Hull, G E Raskob, C J Carter
Nature|July 3, 1980
Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in ratsC J Pycock, R W Kerwin, C J Carter
Blood|March 1, 1982
Sex related differences in platelet function: the effect of aspirinJ G Kelton, C J Carter, A Santos, et al.
Thrombosis Research|May 1, 1980
A comparison of the quantitative ristocetin von Willebrand factor assay by using fresh and fixed plateletsJ G Kelton, J Bishop, C J Carter, et al.
Thrombosis Research|November 1, 1982
Discordance between the anti-Xa activity and the antithrombotic activity in an ultra-low molecular weight heparin fractionP A Ockelford, C J Carter, L Mitchell, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|June 1, 1993
Platelet-associated factor XIII as a marker of platelet activation in patients with peripheral vascular diseaseD V Devine, G Andestad, D Nugent, et al.
Pageof 15